Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 21;16(10):e0258970.
doi: 10.1371/journal.pone.0258970. eCollection 2021.

Clinical characteristics and viral load dynamics of COVID-19 in a mildly or moderately symptomatic outpatient sample

Affiliations

Clinical characteristics and viral load dynamics of COVID-19 in a mildly or moderately symptomatic outpatient sample

Amanda Caplan et al. PLoS One. .

Abstract

Background: Studies of outpatients with mild or moderate COVID-19 are uncommon. We studied: 1) association of symptoms with reverse transcriptase polymerase chain reaction (RT-PCR) test results; and 2) association of initial RT-PCR cycle threshold (Ct) in relation to duration of RT-PCR positivity in outpatients with mild or moderate COVID-19.

Methods: This was a cohort study of outpatients with confirmed COVID-19 and at least one symptom. Participants had repeat nasopharyngeal swabs and symptom checklists every 3-5 days until two consecutive RT-PCR tests were negative. RT-PCR tests were used to assess viral load. Antibody tests for COVID-19 were performed at 2 weeks, 4 weeks, and 8 weeks after symptom onset.

Results: Twenty-five patients (nine females) were enrolled, ranging in age from 19-58 (median age 28 years). All patients reported at least one symptom, with a median of six symptoms per patient. Symptoms persisted for 6-67 days (median duration 18 days). In all 25 patients, blood samples collected a median of 13 days after symptom onset were positive for SARS-CoV-2 antibodies in 15 (60%). After a median of 28 days following symptom onset, 23/23 patients with available samples tested positive for antibodies. The longest duration of positive RT-PCR test was 49 days from first positive PCR test (Mean = 27.4, SD = 12.5, Median = 24). Initial Ct was significantly associated with longer duration (β = -1.3, SE = 0.3, p<0.01 per 1 cycle higher) of RT-PCR positivity.

Conclusions: In mildly or moderately ill COVID-19 outpatients, RT-PCT tests remained positive for as long as 49 days and test positivity and symptom duration correlated with initial viral load.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Viral load evolution for each patient.
Cycle count, measured in samples collected every 3–5 days from first positive RT-PCR test to first of two negative RT-PCR tests, in patients with complete data.
Fig 2
Fig 2. Duration of positive RT-PCR test for SARS-CoV-2 according to initial cycle threshold (Ct).
Duration of positive RT-PCR test was negatively correlated with initial cycle threshold (Ct). Longest duration of positive test in this study was 49 days from symptom onset.
Fig 3
Fig 3. Duration of positive RT-PCR test for SARS-CoV-2 according to number of symptoms.
Duration of positive RT-PCR test was positively associated with number of symptoms. Patients with more symptoms had a positive RT-PCR test significantly longer than patients with fewer symptoms.

Similar articles

Cited by

References

    1. Fontana LM, Villamagna AH, Sikka MK, McGregor JC. Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature. Infect Control Hosp Epidemiol. 2020:1–10. doi: 10.1017/ice.2020.1273 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. Symptoms of Coronavirus 2021 [https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
    1. CITI Program. The CITI Program 2021 [https://about.citiprogram.org/en/homepage/.
    1. National Institutes of Health. Clinical Spectrum of SARS-CoV-2 Infection 2020 [March 21, 2021]. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/.
    1. Centers for Disease Control and Prevention. CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel: Instructions for Use 2020 [CDC-006-00018, Revision 06:[https://www.fda.gov/media/134922/download.

Substances